Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Lunai Bioworks Inc. - Common Stock (NQ:RENB)

1.420 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 30, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	1.420
Bid (Size)	1.530 (5)
Ask (Size)	1.540 (48)
Prev. Close	1.420
Today's Range	1.420 - 1.420
52wk Range	1.214 - 14.00
Shares Outstanding	23,432,391
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

These stocks are moving in today's after hours session ↗

October 01, 2025

The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 25, 2025

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.

Via Benzinga

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	-52.2%	-52.2%
1 Year	-83.0%	-83.0%

More News

Gapping stocks in Thursday's session ↗

September 25, 2025

Via Chartmill

Top movers in Thursday's pre-market session ↗

September 25, 2025

Via Chartmill

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

September 25, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 25, 2025

Via Benzinga

Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket ↗

September 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 24, 2025

Via Benzinga

Top movers in Wednesday's after hours session ↗

September 24, 2025

Via Chartmill

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

September 24, 2025

Via ACCESS Newswire

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women’s Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

September 11, 2025

Via ACCESS Newswire

Top 3 Health Care Stocks You'll Regret Missing In Q3 ↗

September 09, 2025

Via Benzinga

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

September 09, 2025

Via ACCESS Newswire

Lunai Bioworks Strengthens European Strategy Through Restructuring

September 08, 2025

Via ACCESS Newswire

Lunai Bioworks Inc. Retains American Defense International

September 04, 2025

Via ACCESS Newswire

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

August 27, 2025

Via ACCESS Newswire

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

August 19, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

August 08, 2025

Via ACCESS Newswire

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

July 28, 2025

Via ACCESS Newswire

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

July 17, 2025

Via ACCESS Newswire

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

July 09, 2025

Via ACCESS Newswire

These stocks are moving in today's after hours session ↗

June 30, 2025

Via Chartmill

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

June 30, 2025

Via ACCESS Newswire

Tuesday's session: gap up and gap down stocks ↗

June 03, 2025

Via Chartmill

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

June 03, 2025

From Renovaro Inc

Via GlobeNewswire

Frequently Asked Questions

Is Lunai Bioworks Inc. - Common Stock publicly traded?

Yes, Lunai Bioworks Inc. - Common Stock is publicly traded.

What exchange does Lunai Bioworks Inc. - Common Stock trade on?

Lunai Bioworks Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Lunai Bioworks Inc. - Common Stock?

The ticker symbol for Lunai Bioworks Inc. - Common Stock is RENB on the Nasdaq Stock Market

What is the current price of Lunai Bioworks Inc. - Common Stock?

The current price of Lunai Bioworks Inc. - Common Stock is 1.420

When was Lunai Bioworks Inc. - Common Stock last traded?

The last trade of Lunai Bioworks Inc. - Common Stock was at 09/30/25 04:00 PM ET

What is the market capitalization of Lunai Bioworks Inc. - Common Stock?

The market capitalization of Lunai Bioworks Inc. - Common Stock is 33.27M

How many shares of Lunai Bioworks Inc. - Common Stock are outstanding?

Lunai Bioworks Inc. - Common Stock has 33M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.